Fund "Elbrus Kapital" invested 750 million rubles in the Russian company omnikanalny advance of pharmaceutical brands of BREFFI

Bólshaya the part of means will be aimed at development companies, scaling the current businesses and creation of new digital products in the field of health care. From the moment of BREFFI basis the main focus of companies was advance to Russian Federation the branded medicines, mainly through medical community. At the moment at BREFFI more than 100 clients, the majority from which – the international pharmaceutical companies with presence to Russian Federation. BREFFI revenue in 2021 makes more than 500 million rub...